Fetuin-A as a risk factor for arteriovenous fistula failure in chronic kidney disease patients with hemodialysis through vascular calcification mechanism: Systematic review and meta-analysis
The Journal of Vascular Access · 2026
DOI: 10.1177/11297298251407274 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Nyoman Paramita Ayu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine Udayana University/Prof. Ngoerah Hospital, Denpasar, Ba…. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Renal Dialysis, alpha-2-HS-Glycoprotein, Vascular Calcification. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Arteriovenous Fistula (AVF) failure remains a significant challenge in patients on hemodialysis. No meta-analysis has concluded the relationship between fetuin-A serum levels, arterial calcification, and AVF failure. This study aims to evaluate the relationship between fetuin-A levels and AVF failure through vascular calcification in CKD patients undergoing hemodialysis. This meta-analysis was conducted according to the PRISMA guideline. On October 1st, 2024, a literature search was conducted in PubMed and ScienceDirect. Data were analyzed using Review Manager for pooled hazard ratio and standardized mean difference (SMD), while MedCalc software was used to calculate the pooled correlation coefficient. A total of 26 observational studies were included. Meta-analysis showed that fetuin-A levels were negatively correlated with vascular calcification ( r = −0.530; 95% CI: −0.781 to −0.132; p = 0.011). The mean fetuin-A levels were lower in the group with vascular calcification than those without calcification (SMD = −1.71; 95% CI: −2.58 to −0.85; p = 0.0001). Patients with vascular calcification had a 2.98 times higher risk of AVF failure (OR = 2.98; 95% CI: 1.78–4.99; p < 0.0001). Three studies showed that high fetuin-A levels were a protective factor against AVF failure (HR = 0.76; 95% CI: 0.63–0.91; p = 0.003). Low fetuin-A levels were associated with increased vascular calcification and risk of AVF failure in CKD patients undergoing hemodialysis. These findings suggest the potential of fetuin-A as a predictive biomarker and therapeutic target in reducing AVF failure. Further studies with standard testing methods are recommended to confirm this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine Udayana University/Prof. Ngoerah Hospital, Denpasar, Bali, Indonesia.
ORCID-Profile: Nyoman Paramita Ayu, Raka Widiana
Zitieren
APA
Ayu, N. P., Kandarini, Y., Widiana, R., & Mahadita, G. W. (2026). Fetuin-A as a risk factor for arteriovenous fistula failure in chronic kidney disease patients with hemodialysis through vascular calcification mechanism: Systematic review and meta-analysis. The Journal of Vascular Access. https://doi.org/10.1177/11297298251407274
Vancouver
Ayu NP, Kandarini Y, Widiana R, Mahadita GW. Fetuin-A as a risk factor for arteriovenous fistula failure in chronic kidney disease patients with hemodialysis through vascular calcification mechanism: Systematic review and meta-analysis. The Journal of Vascular Access. 2026. doi:10.1177/11297298251407274
BibTeX
@article{Ayu2026,
author = {Ayu, Nyoman Paramita and Kandarini, Yenny and Widiana, Raka and Mahadita, Gede Wira},
title = {Fetuin-A as a risk factor for arteriovenous fistula failure in chronic kidney disease patients with hemodialysis through vascular calcification mechanism: Systematic review and meta-analysis},
journal = {The Journal of Vascular Access},
year = {2026},
doi = {10.1177/11297298251407274}
}
EUVIMED